CRISPRi-mediated functional analysis of lung disease-associated loci at non-coding regions.
Stuart, WD; Guo, M; Fink-Baldauf, IM; Coleman, AM; Clancy, JP; Mall, MA; Lim, F; Brewington, JJ; Maeda, Y.
2020;
2.
An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.
Tomoshige, K; Guo, M; Tsuchiya, T; Fukazawa, T; Fink-Baldauf, IM; Stuart, WD; Naomoto, Y; Nagayasu, T; Maeda, Y.
Oncogene: Including Oncogene Reviews.
2018;
37:3894-3908.
Gene signature driving invasive mucinous adenocarcinoma of the lung.
Guo, M; Tomoshige, K; Meister, M; Muley, T; Fukazawa, T; Tsuchiya, T; Karns, R; Warth, A; Fink-Baldauf, IM; Nagayasu, T; et al.
EMBO Molecular Medicine.
2017;
9:462-481.
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa, T; Guo, M; Ishida, N; Yamatsuji, T; Takaoka, M; Yokota, E; Haisa, M; Miyake, N; Ikeda, T; Okui, T; et al.
Scientific Reports.
2016;
6.